India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Artificial intelligence has shifted from futuristic idea to everyday assistant for real estate professionals. Instead of replacing agents, AI now enhances their workflows—automating repetitive tasks, improving communication, strengthening branding, and turning complex market data into clear insights. From smarter CRMs to AI-powered marketing tools, today’s agents can focus more on relationships and client service while technology handles the busywork behind the scenes.
A Florida House committee is advancing a bill that would crack down on insurers shifting profits to affiliated companies — a practice highlighted by recent investigative reporting. With premiums soaring and options shrinking, the proposed oversight could reshape the state’s insurance landscape and create ripple effects across the real estate market, impacting buyers, agents, and investors statewide.
Proptech podcast *Tangent* marks its 100th episode with an inside look at Airbnb’s evolving role in multifamily housing. Featuring Airbnb Real Estate Marketing Leader Eliza Lochner, the episode explores the rapid growth of Airbnb‑friendly apartments, the rise of flexible‑living models, and why renters and property owners are increasingly embracing hosting as a way to balance affordability, transparency, and control. For today’s real estate professionals—especially in fast‑changing markets like Florida—the conversation highlights major shifts in tenant expectations, property management strategies, and the intersection of technology, hospitality, and residential development.
A Tampa Heights homeowner has joined the growing wave of Floridians dropping property insurance altogether after his 2026 renewal skyrocketed to $14,523. With up to 20% of residents now going bare, experts warn that soaring rates, shrinking coverage options, and post‑storm losses are pushing many to take risky measures — even as alternatives like liability‑only plans, dropped wind coverage, or home‑hardening upgrades may offer relief.
A major ERAS overhaul is coming in 2027, replacing the familiar “publications” field with a more rigorous category called “scholarly works.” Only peer‑reviewed submissions—such as manuscripts, abstracts, book chapters, and presentations—will qualify, shifting greater emphasis toward high‑quality research. While the change aims to give residency directors clearer insight into applicants’ academic contributions, many students worry that advocacy and policy work may lose visibility. As programs lean more heavily on research output in a post–Step 1 pass/fail era, future applicants will need to showcase not just what they’ve produced, but the depth and meaning behind it.
Mortgage rates have ticked back up to 6.25% after a brief dip, signaling a return to stability in the housing market. With rising inventory, moderating prices, and forecasts calling for steady rates through 2026, real estate and finance professionals can expect a more predictable environment ahead. This shift opens the door to smoother transactions, improved buyer confidence, and stronger opportunities for career growth across mortgage, real estate, insurance, and related fields.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
